Incyte (Nasdaq:INCY) disclosed findings from a Phase 2 trial examining povorcitinib (INCB54707), an oral JAK1 inhibitor’s effectiveness and safety among adult patients with prurigo nodularis (PN). These results were presented during a late-breaking oral session (Session: S050 – Late-Breaking Research:…
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, has announced positive results from the Phase 2 KARDIA-2 trial of zilebesiran, an RNAi therapeutic designed to treat hypertension by targeting liver-expressed angiotensinogen (AGT). The trial met its primary endpoint,…
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global leader in insulin delivery and diabetes technology, has announced the pricing of $275.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 (the “notes”) in a private placement. This offering,…
LivaNova PLC (Nasdaq: LIVN), a prominent player in the medical technology sector, has announced the pricing of $300 million aggregate principal amount of 2.50% convertible senior notes due 2029 (referred to as the “notes”). These notes will be issued in…
Amidst projections of the smart home market reaching $345.6 billion by 2032 (Source: IMARC Group), the sector of home healthcare and air purification devices is rapidly growing. Fueled by the COVID-19 pandemic, these products now comprise 11% of the market.…
Aktana, Inc., a pioneer in intelligent customer engagement for the life sciences and medical sector, unveils “Aktana for MedTech,” offering AI-driven tools to enhance representative field execution, account coordination, and medical education programs. Aktana, Inc., a leader in intelligent customer…
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a prominent biopharmaceutical company specializing in innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, has disclosed recent prospective real-world data from early access programs (EAP) affirming the efficacy…
Haemonetics Corporation (NYSE: HAE), a leading global medical technology firm dedicated to enhancing patient outcomes, has revealed its definitive agreement to acquire Attune Medical, a Chicago-based private company renowned for producing the ensoETM® proactive esophageal cooling device. This device, the…
Henry Schein, Inc. (Nasdaq: HSIC), the leading provider of healthcare solutions to dental and medical practitioners, has been honored with the 2024 World’s Most Ethical Companies® recognition by Ethisphere, a renowned authority in setting and promoting ethical business standards globally.…
HCA Healthcare, a leading healthcare provider, has been honored as one of the 2024 World’s Most Ethical Companies by Ethisphere. Recognized for the 14th time, HCA Healthcare stands out in the Healthcare Providers category. CEO Sam Hazen expresses pride in…
Today, Noom, a prominent digital healthcare company dedicated to preventing chronic diseases and promoting healthier lifestyles, announced that Artem Petakov, Co-Founder and President, will transition to a new role as Head of Noom Ventures, effective March 31, 2024. In this…
Dermavant Sciences to Present New ADORING Data on Tapinarof Cream for Atopic Dermatitis at 2024 AAD Annual Meeting Dermavant Sciences, a biopharmaceutical company specializing in innovative therapies for immuno-dermatology, will unveil new ADORING data at the 2024 American Academy of…